Hangzhou Zenshine Pharmaceuticals Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Hangzhou Zenshine Pharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies (NCT04504708) | Hangzhou Zenshine Pharmaceuticals Co., Ltd. | 2021-02-17 |
Track Hangzhou Zenshine Pharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.